These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10148097)

  • 21. Unusual cause of wide complex tachycardia during coronary angiography.
    Kansal MM; Vidovich MI
    Cardiovasc Revasc Med; 2009; 10(1):60-1. PubMed ID: 19159858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of X-ray contrast media on hemostasis and its role in the genesis of adverse reactions].
    Sviridov NK; Napolov IuK
    Vestn Rentgenol Radiol; 2001; (2):62-4. PubMed ID: 11503182
    [No Abstract]   [Full Text] [Related]  

  • 24. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
    Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
    Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.
    Harjai KJ; Raizada A; Shenoy C; Sattur S; Orshaw P; Yaeger K; Boura J; Aboufares A; Sporn D; Stapleton D
    Am J Cardiol; 2008 Mar; 101(6):812-9. PubMed ID: 18328846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephropathy induced by contrast medium.
    Bridges CM; Swaroop VS; Cuddihy MT
    N Engl J Med; 2003 May; 348(22):2257-9; author reply 2257-9. PubMed ID: 12774816
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonionic contrast media: a bargain for some, a burden for many.
    Goel V; Deber RB; Detsky AS
    CMAJ; 1990 Sep; 143(6):480-1. PubMed ID: 2119872
    [No Abstract]   [Full Text] [Related]  

  • 29. Methylene blue as treatment for contrast medium-induced anaphylaxis.
    Evora PR; Oliveira Neto AM; Duarte NM; Vicente WV
    J Postgrad Med; 2002; 48(4):327. PubMed ID: 12571397
    [No Abstract]   [Full Text] [Related]  

  • 30. Contrast-induced nephropathy.
    Pucelikova T; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemodynamics studies with the new generation portable systems: cost-benefit analysis].
    Vergara G
    Ital Heart J Suppl; 2001 Jan; 2(1):22-5. PubMed ID: 11216079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Not every patient with angina requires coronary angiography.
    Hutton I
    Practitioner; 1992 May; 236(1514):570-4. PubMed ID: 1454726
    [No Abstract]   [Full Text] [Related]  

  • 34. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionic versus nonionic contrast media: a burden or a bargain?
    Gafni A; Zylak CJ
    CMAJ; 1990 Sep; 143(6):475-8. PubMed ID: 2119871
    [No Abstract]   [Full Text] [Related]  

  • 36. Nonrecurring transient cortical blindness after coronary angiography: a role for hypoventilation and hypercarbia?
    Danenberg HD; Lotan C
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):384-5. PubMed ID: 16475183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Void of important data in contrast controversy.
    Bettmann MA
    Diagn Imaging (San Franc); 1991 Dec; 13(12):37-40, 113. PubMed ID: 10149749
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of coronary angiography on oxidative DNA damage observed in circulating lymphocytes.
    Demirbag R; Yilmaz R; Kocyigit A; Guzel S
    Angiology; 2007; 58(2):141-7. PubMed ID: 17495261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-osmolality contrast agents--who needs them?
    Hirshfeld JW
    N Engl J Med; 1992 Feb; 326(7):482-4. PubMed ID: 1732775
    [No Abstract]   [Full Text] [Related]  

  • 40. Nonionic vs ionic contrast media: corticosteroid pretreatment in a private practice.
    Seibert CE
    AJR Am J Roentgenol; 1990 Sep; 155(3):652. PubMed ID: 2117370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.